Northwire Canada EditionMonday, July 13, 2026
Sign inSubscribe
Northwire
⌕
GLDN 0.055 +0.0% BRON 0.040 +0.0% BTO 5.43 −0.7% ESK 0.365 −2.7% AUMN 0.275 +0.0% GGX 0.040 +0.0% S 0.155 +29.2% NNX 0.035 +0.0% ABX 51.90 −0.6% TTS 2.40 −4.0% FCI 0.400 −9.1% GR 0.075 +0.0% AII 23.38 +12.4% TUNG 1.72 +1.8% LGO 1.01 −2.9% EMM 0.080 +0.0% GLDN 0.055 +0.0% BRON 0.040 +0.0% BTO 5.43 −0.7% ESK 0.365 −2.7% AUMN 0.275 +0.0% GGX 0.040 +0.0% S 0.155 +29.2% NNX 0.035 +0.0% ABX 51.90 −0.6% TTS 2.40 −4.0% FCI 0.400 −9.1% GR 0.075 +0.0% AII 23.38 +12.4% TUNG 1.72 +1.8% LGO 1.01 −2.9% EMM 0.080 +0.0%

Healthcare

Page 31
  1. Apr 20, 2026 · 18:00 · SKNY · Neutral

    LIR Life Sciences Corp.

    LIR Life Sciences Corp. Announces Agreement with Resilience BioSciences Inc.

    01
  2. Apr 20, 2026 · 17:25 · NVRS · Material −

    Noveris Health Sciences Inc.

    Noveris Health Sciences Inc. Provides Clarifying News Release Regarding Life Offering And Other Disclosure

    02
  3. Apr 20, 2026 · 09:15 · OTC · Routine +

    Clinical Validation Confirmed, But Capital Constraints Remain Key Risk

    Ocumetics Reports Improvement in Six Month First-in-Human Results Meaningful Improvements in Patient Quality of Life

    03
  4. Apr 20, 2026 · 08:50 · VPT · Routine +

    Ventripoint Wins Gold Edison Award But Cash Burn and Dilution Risks Persist

    Ventripoint's VMS+(TM) 4.0 Recognized with Gold Edison Award, Validating Leadership and Future Potential

    04
  5. Apr 20, 2026 · 08:30 · KETA · Routine −

    Legal Scrutiny Amidst Capital Erosion

    TripSitter Announces Discovery Notice

    05
  6. Apr 20, 2026 · 08:15 · HELP · Routine −

    Management Instability Clouds Near-Term Catalysts Despite Strong Cash Position

    Helus Pharma Expresses Support for Executive Order Advancing Psychedelic Research and Regulatory Pathways for Serious Mental Health Conditions

    06
  7. Apr 20, 2026 · 08:01 · PHRM · Routine +

    PharmaTher Seeks Regulatory Tailwinds Amidst Price Slump

    PharmaTher's Microneedle Patch Platforms Positioned to Benefit from Major U.S. Catalysts in Psychedelics and Peptides

    07
  8. Apr 20, 2026 · 08:00 · HELP · Material −

    Tagline: Leadership Turmoil Overshadows Clinical Wins as Helus Pharma CEO Departs Ahead of Pivotal Phase 3 Readout

    Helus Pharma Announces Chief Executive Officer Transition; Eric So to Resume Role as Interim Chief Executive Officer

    08
  9. Apr 20, 2026 · 08:00 · CSCI · Routine +

    COSCIENS Biopharma Proposes Share Consolidation to Cut Reporting Costs and Exit U.S. Registry

    COSCIENS Biopharma Inc. Provides Update on its Plan to Suspend U.S. Public Company Reporting Obligations

    09
  10. Apr 20, 2026 · 07:30 · BCT · Routine +

    BriaCell Stabilizes Near Multi-Year Lows as Phase 3 QOL Data Validates Safety Profile Ahead of Top-Line Efficacy Readout

    BriaCell Presents Positive Phase 3 Quality of Life and Phase 2 Biomarker Data at the 2026 AACR Meeting

    10
  11. Apr 20, 2026 · 07:01 · EYE · Routine +

    Micro-cap optical tech firm secures US commercialization partner

    Rise Nano Optics Announces Strategic Partnership with Sierra Optical Lab to Produce and Commercialize SpectraGuard(TM) Lenses in the United States

    11
  12. Apr 20, 2026 · 07:00 · AIAI · Routine +

    NetraMark Commentary on Psychedelic Executive Order Fails to Halt Downtrend Despite Insider Buying

    Netramark Comments on U.S. Executive Order to Accelerate Treatments for Serious Mental Illness and Highlights the Need for Regulatory-Grade Trial Design in Psychedelic Development

    12
  13. Apr 20, 2026 · 07:00 · CNVI · Routine +

    FDA Clearance Confirms Timeline, But Cash Burn Threatens Commercial Launch Viability

    Conavi Medical Announces FDA 510(k) Clearance of its Next-Generation Hybrid IVUS-OCT System for Intravascular Imaging

    13
  14. Apr 20, 2026 · 06:00 · LOBE · Routine +

    Lobe Sciences Secures Funding for Sickle Cell Candidate Amid Balance Sheet Strengthening

    Lobe Sciences Ltd. Announces Closing of Non-Brokered Private Placement and Provides Corporate Update

    14
← Newer Older →